Development and validation of the outburst monitoring scale for children and adolescents

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: The aim of this study was to develop a parent-completed questionnaire measure of specific types of aggressive behaviors in children and adolescents. Method: Two studies tested the psychometrics of the Outburst Monitoring Scale (OMS), a questionnaire measure of verbal, property, self, and physical aggression, based in part on the categories of the Overt Aggression Scale. In Study 1, parents of 23 adolescents with a history of aggressive-disruptive behavior and 30 control adolescents completed the OMS and other measures of aggressive-disruptive behavior. In Study 2, parents of 9 adolescents with a history of aggressive-disruptive behavior completed the OMS and other measures of aggressive-disruptive behavior during open-label treatment with methylphenidate and quetiapine. Results: Results from both studies demonstrated adequate internal consistency of OMS subscale and total scores. OMS scores correlated significantly with measures of conduct disorder and oppositional defiant disorder and differentiated between control and aggressive subsamples. Changes in OMS scores during treatment correlated with changes in other measures of aggressive and disruptive behavior. Conclusion: The OMS demonstrated good internal consistency, strong correlations with other measures of aggressive/disruptive behavior, good differential validity, and sensitivity to change during a medication trial. The OMS offers a quick, valid, questionnaire-based alternative for measuring frequencies of specific aggressive behaviors in clinical and research settings.

Original languageEnglish
Pages (from-to)511-526
Number of pages16
JournalJournal of Child and Adolescent Psychopharmacology
Volume17
Issue number4
DOIs
StatePublished - Aug 2007

Fingerprint

Aggression
Parents
Attention Deficit and Disruptive Behavior Disorders
Conduct Disorder
Adolescent Behavior
Methylphenidate
Behavior Control
Child Behavior
Psychometrics
Problem Behavior
Therapeutics
Research
Surveys and Questionnaires
Quetiapine Fumarate

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Development and validation of the outburst monitoring scale for children and adolescents. / Kronenberger, William; Giauque, Ann L.; Dunn, David.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 17, No. 4, 08.2007, p. 511-526.

Research output: Contribution to journalArticle

@article{dac349564992482ab629f16125daa0c2,
title = "Development and validation of the outburst monitoring scale for children and adolescents",
abstract = "Objective: The aim of this study was to develop a parent-completed questionnaire measure of specific types of aggressive behaviors in children and adolescents. Method: Two studies tested the psychometrics of the Outburst Monitoring Scale (OMS), a questionnaire measure of verbal, property, self, and physical aggression, based in part on the categories of the Overt Aggression Scale. In Study 1, parents of 23 adolescents with a history of aggressive-disruptive behavior and 30 control adolescents completed the OMS and other measures of aggressive-disruptive behavior. In Study 2, parents of 9 adolescents with a history of aggressive-disruptive behavior completed the OMS and other measures of aggressive-disruptive behavior during open-label treatment with methylphenidate and quetiapine. Results: Results from both studies demonstrated adequate internal consistency of OMS subscale and total scores. OMS scores correlated significantly with measures of conduct disorder and oppositional defiant disorder and differentiated between control and aggressive subsamples. Changes in OMS scores during treatment correlated with changes in other measures of aggressive and disruptive behavior. Conclusion: The OMS demonstrated good internal consistency, strong correlations with other measures of aggressive/disruptive behavior, good differential validity, and sensitivity to change during a medication trial. The OMS offers a quick, valid, questionnaire-based alternative for measuring frequencies of specific aggressive behaviors in clinical and research settings.",
author = "William Kronenberger and Giauque, {Ann L.} and David Dunn",
year = "2007",
month = "8",
doi = "10.1089/cap.2007.0094",
language = "English",
volume = "17",
pages = "511--526",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Development and validation of the outburst monitoring scale for children and adolescents

AU - Kronenberger, William

AU - Giauque, Ann L.

AU - Dunn, David

PY - 2007/8

Y1 - 2007/8

N2 - Objective: The aim of this study was to develop a parent-completed questionnaire measure of specific types of aggressive behaviors in children and adolescents. Method: Two studies tested the psychometrics of the Outburst Monitoring Scale (OMS), a questionnaire measure of verbal, property, self, and physical aggression, based in part on the categories of the Overt Aggression Scale. In Study 1, parents of 23 adolescents with a history of aggressive-disruptive behavior and 30 control adolescents completed the OMS and other measures of aggressive-disruptive behavior. In Study 2, parents of 9 adolescents with a history of aggressive-disruptive behavior completed the OMS and other measures of aggressive-disruptive behavior during open-label treatment with methylphenidate and quetiapine. Results: Results from both studies demonstrated adequate internal consistency of OMS subscale and total scores. OMS scores correlated significantly with measures of conduct disorder and oppositional defiant disorder and differentiated between control and aggressive subsamples. Changes in OMS scores during treatment correlated with changes in other measures of aggressive and disruptive behavior. Conclusion: The OMS demonstrated good internal consistency, strong correlations with other measures of aggressive/disruptive behavior, good differential validity, and sensitivity to change during a medication trial. The OMS offers a quick, valid, questionnaire-based alternative for measuring frequencies of specific aggressive behaviors in clinical and research settings.

AB - Objective: The aim of this study was to develop a parent-completed questionnaire measure of specific types of aggressive behaviors in children and adolescents. Method: Two studies tested the psychometrics of the Outburst Monitoring Scale (OMS), a questionnaire measure of verbal, property, self, and physical aggression, based in part on the categories of the Overt Aggression Scale. In Study 1, parents of 23 adolescents with a history of aggressive-disruptive behavior and 30 control adolescents completed the OMS and other measures of aggressive-disruptive behavior. In Study 2, parents of 9 adolescents with a history of aggressive-disruptive behavior completed the OMS and other measures of aggressive-disruptive behavior during open-label treatment with methylphenidate and quetiapine. Results: Results from both studies demonstrated adequate internal consistency of OMS subscale and total scores. OMS scores correlated significantly with measures of conduct disorder and oppositional defiant disorder and differentiated between control and aggressive subsamples. Changes in OMS scores during treatment correlated with changes in other measures of aggressive and disruptive behavior. Conclusion: The OMS demonstrated good internal consistency, strong correlations with other measures of aggressive/disruptive behavior, good differential validity, and sensitivity to change during a medication trial. The OMS offers a quick, valid, questionnaire-based alternative for measuring frequencies of specific aggressive behaviors in clinical and research settings.

UR - http://www.scopus.com/inward/record.url?scp=34548668933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548668933&partnerID=8YFLogxK

U2 - 10.1089/cap.2007.0094

DO - 10.1089/cap.2007.0094

M3 - Article

VL - 17

SP - 511

EP - 526

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 4

ER -